ReviewJournal of diabetes science and technology2026
Continuous Glucose Monitoring in Older People With Diabetes Mellitus and Cognitive Impairment: A Brief Review.
Review in Journal of diabetes science and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus and dementia are common chronic diseases affecting older people in the community and in hospitals. Even though both diseases have been independently well-characterized, comorbid diabetes and dementia/cognitive impairment are much less understood. In particular, cognitive impairment can make glucose monitoring much more challenging and can more readily lead to diabetes-related emergencies such as hypoglycemia, hyperosmolar hyperglycemic state, or diabetic ketoacidosis. Based on this, improving diabetes management in the community and in the hospital settings via glucose monitoring is essential in older people with T2DM and particularly those with comorbid diabetes and dementia.
aimThe use of continuous glucose monitoring (CGM) holds promise for greater glycemic management in older patients with diabetes and those at high risk for dementia. In this brief review, we will review the few existing studies for CGM use in the community and the hospital in this population, as well as the link between hospital admissions.
resultsExisting studies show high feasibility and good adherence with using CGM among older people. In addition, diabetes technologies can improve risk factors associated with hospitalization, leading to decreased hospitalization rates. We illustrate how the current studies highlight the need for studies in the hospital in this frail population, who potentially will benefit most from CGM systems.
conclusionAlthough existing feasibility studies show high promise in this frail population, more data are needed on CGM for older people living with diabetes and memory problems in the hospital setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.